| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 49.71 | 10.3% | 312.8% |
| Total Income | 50.08 | 11.3% | 293.2% |
| Expenditure | 49.83 | 8.7% | 333.6% |
| PBT | 0.26 | 86.1% | 79.3% |
| Net Profit | -0.17 | 112.8% | 114.3% |
| OPM | 1.93% | 1.67pp | 5.87pp |
| NPM | -0.35% | 2.75pp | 9.89pp |
| EPS | 0.00 | 100.0% | 100.0% |
Diversified/other core-profit lens shows a swing from a ₹1.22cr profit to a ₹0.17cr net loss with OPM collapsing from 7.8% to 1.9% and NPM turning negative, so the 313% revenue jump (off a tiny, low base) doesn't offset a genuine deterioration in profitability.
Genpharmasec Partners Amneal Healthcare for ₹75 Cr Annual Sales Commitment
13 Aug 2026 · 13 Aug, 5:00 pm
Summary
Genpharmasec Limited announced a significant Super Stockist agreement with Amneal Healthcare Private Limited (AHPL). This partnership will see Genpharmasec distributing AHPL's pharmaceutical products to pharmacists within a designated territory. A key aspect of the agreement is AHPL's commitment to a minimum annual sales target of approximately INR 75 Crores for Genpharmasec. Management expressed enthusiasm for this development, viewing it as a crucial step in expanding their market reach and enhancing distribution networks, ultimately benefiting customers with increased access to quality healthcare products.
Key Highlights
- 1
Genpharmasec Limited has entered into a non-exclusive Super Stockist agreement with Amneal Healthcare Private Limited (AHPL).
- 2
Under this agreement, Genpharmasec will sell AHPL's manufactured products to wholesale and retail pharmacists within a specified territory.
- 3
AHPL has committed to a minimum annual sales commitment of approximately INR 75 Crores to Genpharmasec for each calendar year during the agreement term.
- 4
This collaboration is expected to expand Genpharmasec's market presence and strengthen its distribution capabilities.
- 5
The agreement aims to offer a wider range of high-quality healthcare products, enhancing accessibility and service excellence for customers.
Management Comments
Rajesh Sadhwani
We are excited to enter into a Super Stockist Agreement with AHPL, a highly respected name in the healthcare industry. This agreement represents a key step forward in our commitment to expanding our presence in the market and strengthening our distribution capabilities. By working with AHPL, we will be able to offer an even wider range of high-quality healthcare products to our customers, ensuring greater accessibility and service excellence. This collaboration is not only a testament to the trust and synergy between our organizations but also lays the foundation for sustained growth and mutual success in the years to come. We look forward to a fruitful partnership with AHPL and are confident that it will bring significant value to both parties.
Informational and educational content only. Not investment advice.